(Q40580538)

English

Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia

scientific article published on May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia (English)

1 reference

Europe PubMed Central

21 September 2017

neurodegeneration

1 reference

based on heuristic

inferred from title

author name string

Esther O'Shea

1

1 reference

Europe PubMed Central

21 September 2017

N Easton

2

1 reference

Europe PubMed Central

21 September 2017

J R Fry

3

1 reference

Europe PubMed Central

21 September 2017

A R Green

4

1 reference

Europe PubMed Central

21 September 2017

C A Marsden

5

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

21 September 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

21 September 2017

81

1 reference

Europe PubMed Central

21 September 2017

4

1 reference

Europe PubMed Central

21 September 2017

686-695

1 reference

Europe PubMed Central

21 September 2017

Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Enzyme-catalysed conjugations of glutathione with unsaturated compounds

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Effect of diethylmaleate and other glutathione depletors on protein synthesis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Glutathione depletion and resynthesis in laboratory animals

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Orally administered MDMA causes a long-term depletion of serotonin in rat brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Glutathione: interorgan translocation, turnover, and metabolism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Origin and turnover of mitochondrial glutathione

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Ecstasy and the dance of death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Major metabolites of(±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Modulation of glutathione conjugation in vivo: how to decrease glutathione conjugation in vivo or in intact cellular systems in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Brain uptake of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine, the glutathione and cysteine S-conjugates of the neurotoxin dichloroacetylene.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Relationship between glutathione content in liver and glutathione conjugation rate in the rat in vivo. Effect of buthionine sulphoximine pretreatment on conjugation of the two 2-bromoisovalerylurea enantiomers during intravenous infusion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Neurotoxicity of MDMA: neurochemical effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Glucocorticoids and hypothermic induction and survival in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00844.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2002.00844.X

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40580538&oldid=2165893345"